I plan to hold every one of my shares until late this year when we should hear about the FDA's decision on ANX-514...That's really the main reason I'm here, as ANX-530 is a drop in the bucket compared to 514...
If the company gets bought out before the end of the year, I'll have to decide if it's a keeper or not...That will depend on who buys it out, and what the circumstances were...
I'm not one to "kiss and tell", so I won't mention the exact number of shares I own...I will say that it's a LOT, but not enough to have to file with the SEC as a 5% owner of the company (when the Float was only 157 million shares)...And the price I got them at is all under $.20 so I was only under water the day the Refuse-to-File Letter came out on March 1st, and that didn't last long...
Looking back in retrospect, I could've made a small fortune if I had sold all my shares at $.50 or so...But I decided when I bought my shares, that I was going to hold onto all of them the entire year of 2010 unless a buyout happened this year...
I really didn't anticipate the trouble the company had with the NDA for 530, and I am sure the share price would be much higher if the FDA had accepted the NDA...
Don't get me started on my conspiracy theories as to what powers may have influenced the FDA's decision so that the share price would fall sharply to be accumulated by deep pockets...Last week's Shelf Registration was the company's reaction to that hostile takeover threat...IMO